KYORIN Pharmaceutical Co., Ltd.
KYORIN Pharmaceutical Co., Ltd. scores highest on Price (55) and lowest on Nitro (10). Its PosiPenta is 38.52 out of 100, weaker than most similar companies.
On the Penta Grid this week, KYORIN Pharmaceutical Co., Ltd. is Grid #23 of 24 in the Healthcare sector in Japan, and Grid #354 of 413 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| KYORIN Pharmaceutical Co., Ltd. | 38.52 | 55 | 54 | 10 | 30 | 43 |
| Vital KSK Holdings, Inc. | 66.25 | 90 | 59 | 77 | 47 | 57 |
| Japan Eyewear Holdings Co., Ltd. | 46.73 | 47 | 46 | 36 | 56 | 49 |
| Zeria Pharmaceutical Co., Ltd. | 56.59 | 86 | 62 | 37 | 40 | 57 |
| EM Systems Co., Ltd. | 41.84 | 28 | 41 | 21 | 59 | 61 |
| Amvis Holdings, Inc. | 41.70 | 74 | 55 | 20 | 28 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 29.37 |
| P/B ratio | 0.45 |
EEarnings
| Trailing EPS | ₹22.88 |
| Forward EPS | ₹63.56 |
NNitro
| Price | 671.95 |
| 52-week high | 1044.25 |
| 52-week low | 633.21 |
| Fall from 52-week high | 35.7% |
TTorque
| Return on equity (ROE) | 1.57% |
| Debt-to-equity | 0.17 |
AAnchor
| Beta (price swings) | -0.02 |
| Market cap | ₹3,860 Cr |
| Insider holding | 35.81% |
| Dividend yield | 4.15% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is KYORIN Pharmaceutical Co., Ltd.'s PosiPenta score?
KYORIN Pharmaceutical Co., Ltd.'s PosiPenta is 38.52 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does KYORIN Pharmaceutical Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, KYORIN Pharmaceutical Co., Ltd. is Grid #23 of 24 in the Healthcare sector in Japan, and Grid #354 of 413 in Japan.
Which PosiPenta pillar is strongest for KYORIN Pharmaceutical Co., Ltd.?
Price (valuation), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for KYORIN Pharmaceutical Co., Ltd.?
Nitro (momentum), with a score of 10 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.